Karl H. Tully

Access denied: The relationship between patient insurance status and access to high‐volume hospitals

Junaid Nabi, Karl H. Tully, Alexander P. Cole et al. · Cancer · 2020 · 54 citations · Full text

Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy

Marieke J. Krimphove, Julie Szymaniak, Maya Marchese et al. · European Urology Focus · 2019 · 48 citations

Urological Research, Urology, Surgical Oncology +6

C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma

Niklas Klümper, Danijel Sikic, Jonas Saal et al. · European Journal of Cancer · 2022 · 34 citations · Full text

Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy

Karl H. Tully, David‐Dan Nguyen, Peter Herzog et al. · European Urology Oncology · 2019 · 33 citations

Urology, Psychiatry, Geriatrics +6

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma

Marieke J. Krimphove, Karl H. Tully, David F. Friedlander et al. · Journal for ImmunoTherapy of Cancer · 2019 · 31 citations · Full text